Inventiva IVA
NASDAQ IVA
$4.78 -0.06 (-1.24%)
As of: Sep 4, 2026 · 3:59 PM EDT

Inventiva (IVA) Selling, General & Administrative (2019 - 2021)

Analysis

Inventiva (IVA) Selling, General & Administrative (2019 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 582.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 662.10 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -417.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 216.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 110.21 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 593.21 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 347.92 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 161.89 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 247.47 Mn
10 Inventiva 893.85 Mn 893.85 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -3.66 Mn
Mar 31, 2021 -3.30 Mn
Dec 31, 2020 -10.13 Mn
Jun 30, 2020 -2.02 Mn
Mar 31, 2020 -1.71 Mn
Dec 31, 2019 -6.74 Mn